Masaru Kuranami

1.6k citations

45 papers · 1.3k indexed · h-index 18

Radiology, Nuclear Medicine and Imaging top 2%
Oncology top 10%
Pulmonary and Respiratory Medicine
Cancer Research
Pathology and Forensic Medicine top 10%

Co-authors: Keiichi Iwabuchi Reiko Woodhams Shinichi Kan Hirofumi Hata Keiji Matsunaga Kazushige Hayakawa Masahiko Watanabe Masanori Ozaki
Topics: Cancer Treatment and Pharmacology (11 papers)Breast Cancer Treatment Studies (8 papers)Family Support in Illness (6 papers)
Cited by: Radiology, Nuclear Medicine and Imaging Oncology Cancer Research
Journals: Journal of Clinical Oncology JNCI Journal of the National Cancer Institute Cancer
Partner nations: Japan United States United Kingdom

In The Last Decade

Masaru Kuranami

42 papers receiving 1.3k citations

Peers

Countries citing papers authored by Masaru Kuranami

Since Specialization

Citations

This map shows the geographic impact of Masaru Kuranami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaru Kuranami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaru Kuranami more than expected).

Fields of papers citing papers by Masaru Kuranami

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masaru Kuranami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaru Kuranami. The network helps show where Masaru Kuranami may publish in the future.

Co-authorship network of co-authors of Masaru Kuranami

This figure shows the co-authorship network connecting the top 25 collaborators of Masaru Kuranami. A scholar is included among the top collaborators of Masaru Kuranami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masaru Kuranami. Masaru Kuranami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comparison of an AC‐taxane versus AC‐free regimen and paclitaxel versus docetaxel in patients with lymph node‐positive breast cancer: Final results of the National Surgical Adjuvant Study of Breast Cancer 02 trial, a randomized comparative phase 3 study 2017 ·Cancer ·Toru Watanabe,Masaru Kuranami,Kenichi Inoue,Norikazu Masuda,Kenjiro Aogi,Shinji Ohno,Hiroji Iwata,Hirofumi Mukai,Yukari Uemura,Yasuo Ohashi	28
2	Prognostic significance of Ki-67 in chemotherapy-naive breast cancer patients with 10-year follow-up. 2014 ·PubMed ·Hiroshi Nishimiya,Yoshimasa Kosaka,Keishi Yamashita,(unknown),Mariko Kikuchi,Akira Ema,Kazunori Nakamura,Mina Waraya,(unknown),Hirokazu Tanino,Masaru Kuranami,Masahiko Watanabe,(unknown)	13
3	The Relationship Between Emotional Suppression and Psychological Distress in Breast Cancer Patients After Surgery 2014 ·Japanese Journal of Clinical Oncology ·Yuki Nakatani,Yumi Iwamitsu,Masaru Kuranami,(unknown),(unknown),Kenji Yamamoto,Masahiko Watanabe,Hiroaki Miyaoka	22
4	Predictors of psychological distress in breast cancer patients after surgery 2013 ·Yuki Nakatani,Yumi Iwamitsu,Masaru Kuranami	9
5	[Efficacy and safety of lidocaine hydrochloride jelly for the treatment of pain caused by breast cancer metastases to the skin]. 2012 ·PubMed ·Mina Waraya,Yoshimasa Kosaka,(unknown),Mariko Kikuchi,Hiroshi Nishimiya,(unknown),Masaru Kuranami,Masahiko Watanabe	1
6	Vascular endothelial growth factor receptor-1 mRNA overexpression in peripheral blood as a useful prognostic marker in breast cancer 2012 ·Breast Cancer Research ·Yoshimasa Kosaka,Akemi Kataoka,Hiroshi Yamaguchi,Hiroaki Ueo,Sayuri Akiyoshi,(unknown),Masaru Kuranami,Shinji Ohno,Masahiko Watanabe,Koshi Mimori,Masaki Mori	7
7	Randomized phase II study of three doses of oral TAS‐108 in postmenopausal patients with metastatic breast cancer 2012 ·Cancer Science ·Hideo Inaji,Hiroji Iwata,Takahiro Nakayama,Naohito Yamamoto,Yasuyuki Sato,Yutaka Tokuda,Kenjiro Aogi,Shigehira Saji,Kenichi Watanabe,Tsuyoshi Saito,Masayuki Yoshida,Nobuaki Sato,Toshiaki Saeki,Yuichi Takatsuka,Masaru Kuranami,Hiroko Yamashita,Atsushi Kikuchi,Toshio Tabei,Tadashi Ikeda,Shinzaburo Noguchi	6
8	Taxane-induced peripheral neuropathy and health-related quality of life in postoperative breast cancer patients undergoing adjuvant chemotherapy: N-SAS BC 02, a randomized clinical trial 2012 ·Supportive Care in Cancer ·Kojiro Shimozuma,Yasuo Ohashi,Ayano Takeuchi,Toshihiko Aranishi,Satoshi Morita,Katsumasa Kuroi,Shozo Ohsumi,Haruhiko Makino,Noriyuki Katsumata,Masaru Kuranami,Kimito Suemasu,Toru Watanabe,Frederick H. Hausheer	79
9	Cognitive function in women with breast cancer receiving adjuvant chemotherapy and healthy controls 2012 ·Breast Cancer ·(unknown),Yumi Iwamitsu,Masaru Kuranami,(unknown),(unknown),Yuki Nakatani,Kenji Yamamoto,Masahiko Watanabe,Hitoshi Miyaoka	37
10	Comparison of EQ-5D Scores among Anthracycline-Containing Regimens followed by Taxane and Taxane-Only Regimens for Node-Positive Breast Cancer Patients after Surgery: The N-SAS BC 02 Trial 2011 ·Value in Health ·Takeru Shiroiwa,Takashi Fukuda,Kojiro Shimozuma,Masaru Kuranami,Kimito Suemasu,Yasuo Ohashi,Toru Watanabe	10
11	Concerns about inherited risk of breast cancer prior to diagnosis in Japanese patients with breast complaints 2011 ·Familial Cancer ·Noriko Ando,Yumi Iwamitsu,Masaru Kuranami,(unknown),Kenji Yamamoto,Masahiko Watanabe,Hitoshi Miyaoka	2
12	A phase III open-label study to assess safety and efficacy of palonosetron for preventing chemotherapy-induced nausea and vomiting (CINV) in repeated cycles of emetogenic chemotherapy 2011 ·Supportive Care in Cancer ·Kenjiro Aogi,Hiroshi Sakai,Hirohisa Yoshizawa,Norikazu Masuda,Nobuyuki Katakami,Yasuhiro Yanagita,Kenichi Inoue,Masaru Kuranami,Mitsuhiro Mizutani,Noriyuki Masuda	24
13	Identification of Residual Breast Carcinoma Following Neoadjuvant Chemotherapy: Diffusion-weighted Imaging—Comparison with Contrast-enhanced MR Imaging and Pathologic Findings 2010 ·Radiology ·Reiko Woodhams,Satoko Kakita,Hirofumi Hata,Keiichi Iwabuchi,Masaru Kuranami,Shiva Gautam,Hiroto Hatabu,Shinichi Kan,Carolyn E. Mountford	113
14	The psychological responses of outpatient breast cancer patients before and during first medical consultation 2009 ·Palliative & Supportive Care ·(unknown),Yumi Iwamitsu,Masaru Kuranami,(unknown),(unknown),Kenji Yamamoto,(unknown),Masahiko Watanabe,Hitoshi Miyaoka	8
15	Interaction Between Stromal Fibroblasts and Colorectal Cancer Cells in the Expression of Vascular Endothelial Growth Factor 2006 ·Journal of Surgical Research ·(unknown),Masaru Kuranami,Masahiko Watanabe	20
16	ADC Mapping of Benign and Malignant Breast Tumors 2005 ·Magnetic Resonance in Medical Sciences ·Reiko Woodhams,Keiji Matsunaga,Shinichi Kan,Hirofumi Hata,Masanori Ozaki,Keiichi Iwabuchi,Masaru Kuranami,Masahiko Watanabe,Kazushige Hayakawa	278
17	Specific Enhanced Expression of Platelet-Derived Endothelial Cell Growth Factor in Submucosa of Human Colorectal Cancer 2004 ·Diseases of the Colon & Rectum ·(unknown),(unknown),(unknown),Yuichi Sato,Masaru Kuranami	12
18	Pharmacokinetics of capecitabine (Xeloda) in Japanese and Caucasian patients with breast cancer 2003 ·Cancer Chemotherapy and Pharmacology ·Bruno Reigner,Toru Watanabe,(unknown),Helen Lucraft,Yasutsuna Sasaki,John Bridgewater,Toshiaki Saeki,(unknown),Masaru Kuranami,Christopher Poole,(unknown),(unknown),(unknown),E. Weidekamm,Susan Grange	41
19	Analyses of protein kinase c isoform expression in a colorectal cancer liver metastasis model 1995 ·The American Journal of Surgery ·Masaru Kuranami,Alfred M. Cohen,José G. Guillem	8
20	In vitro Sensitivity Test of Breast Cancer Cells to Hormonal Agents in a Radionucleotide‐incorporation Assay 1990 ·Japanese Journal of Cancer Research ·Toru Watanabe,(unknown),Kiyoshi Morikawa,Masahiro Fuchigami,Masaru Kuranami,Isamu Adachi,Ken Yamaguchi,Kaoru Abe	11

About Masaru Kuranami

Masaru Kuranami is a scholar working on Oncology, Dermatology and Cancer Research, having authored 45 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (11 papers), Breast Cancer Treatment Studies (8 papers) and Family Support in Illness (6 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (646 citations), Oncology (409 citations) and Cancer Research (146 citations). Masaru Kuranami has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Keiichi Iwabuchi, Reiko Woodhams, Shinichi Kan, Hirofumi Hata, Keiji Matsunaga, Kazushige Hayakawa, Masahiko Watanabe, Masahiko Watanabe, Masanori Ozaki and Yumi Iwamitsu. Their work appears in journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact